Astellas Pharma Inc.

TSE:4503 주식 보고서

시가총액: JP¥3.2t

Astellas Pharma 관리

관리 기준 확인 1/4

Astellas Pharma CEO는 Naoki Okamura, Apr2023 에 임명되었습니다 의 임기는 1.58 년입니다. 총 연간 보상은 ¥ 461.00M, 29.5% 로 구성됩니다. 29.5% 급여 및 70.5% 보너스(회사 주식 및 옵션 포함). 는 ¥ 101.41M 가치에 해당하는 회사 주식의 0.003% 직접 소유합니다. 101.41M. 경영진과 이사회의 평균 재임 기간은 각각 4.8 년과 1.4 년입니다.

주요 정보

Naoki Okamura

최고 경영자

JP¥461.0m

총 보상

CEO 급여 비율29.5%
CEO 임기1.6yrs
CEO 소유권0.003%
경영진 평균 재임 기간4.8yrs
이사회 평균 재임 기간1.4yrs

최근 관리 업데이트

Recent updates

Astellas Pharma Inc. (TSE:4503) Just Released Its Half-Yearly Earnings: Here's What Analysts Think

Nov 01
Astellas Pharma Inc. (TSE:4503) Just Released Its Half-Yearly Earnings: Here's What Analysts Think

Astellas Pharma Inc.'s (TSE:4503) Earnings Haven't Escaped The Attention Of Investors

Oct 15
Astellas Pharma Inc.'s (TSE:4503) Earnings Haven't Escaped The Attention Of Investors

Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00

Sep 24
Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00

Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00

Sep 03
Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00

Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00

Aug 20
Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00

Earnings Beat: Astellas Pharma Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 04
Earnings Beat: Astellas Pharma Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Astellas Pharma's (TSE:4503) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 26
Astellas Pharma's (TSE:4503) Shareholders Will Receive A Bigger Dividend Than Last Year

Astellas Pharma (TSE:4503) Is Paying Out A Larger Dividend Than Last Year

Jul 11
Astellas Pharma (TSE:4503) Is Paying Out A Larger Dividend Than Last Year

Is Astellas Pharma (TSE:4503) A Risky Investment?

Jun 14
Is Astellas Pharma (TSE:4503) A Risky Investment?

Astellas Pharma's (TSE:4503) Soft Earnings Are Actually Better Than They Appear

May 02
Astellas Pharma's (TSE:4503) Soft Earnings Are Actually Better Than They Appear

Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 29
Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Why We're Not Concerned About Astellas Pharma Inc.'s (TSE:4503) Share Price

Feb 29
Why We're Not Concerned About Astellas Pharma Inc.'s (TSE:4503) Share Price

CEO 보상 분석

Naoki Okamura 의 보수는 Astellas Pharma 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

JP¥55b

Jun 30 2024n/an/a

JP¥22b

Mar 31 2024JP¥461mJP¥136m

JP¥17b

Dec 31 2023n/an/a

JP¥4b

Sep 30 2023n/an/a

JP¥38b

Jun 30 2023n/an/a

JP¥107b

Mar 31 2023JP¥204mJP¥70m

JP¥99b

Dec 31 2022n/an/a

JP¥136b

Sep 30 2022n/an/a

JP¥149b

Jun 30 2022n/an/a

JP¥118b

Mar 31 2022n/an/a

JP¥124b

Dec 31 2021n/an/a

JP¥120b

Sep 30 2021n/an/a

JP¥119b

Jun 30 2021n/an/a

JP¥101b

Mar 31 2021JP¥236mJP¥70m

JP¥121b

Dec 31 2020n/an/a

JP¥138b

Sep 30 2020n/an/a

JP¥140b

Jun 30 2020n/an/a

JP¥187b

Mar 31 2020JP¥232mJP¥53m

JP¥195b

보상 대 시장: Naoki 의 총 보상 ($USD 3.03M )은 JP 시장( $USD 1.39M ).

보상과 수익: Naoki 의 보상은 지난 1년 동안 20% 이상 증가했습니다.

CEO

Naoki Okamura (62 yo)

1.6yrs

테뉴어

JP¥461,000,000

보상

Mr. Naoki Okamura, BSc, served as Chief Business Officer at Astellas Pharma Inc. since September 2021 until 2022. He served as Executive Vice President at Astellas Pharma Inc. since 2021 until April 1, 202...

리더십 팀

이름위치테뉴어보상소유권
Naoki Okamura
President1.6yrsJP¥461.00m0.0032%
¥ 101.4m
Atsushi Kitamura
Senior Executive Officer & CFO1.8yrs데이터 없음데이터 없음
Nobue Yasuda
General Manager of Finance & Accounting Departmentno data데이터 없음데이터 없음
Yoshitsugu Shitaka
Chief Scientific Officer & Senior Managing Executive Officer3.8yrs데이터 없음데이터 없음
Catherine Levitt
General Counselno data데이터 없음데이터 없음
Katsuyoshi Sugita
Chief People Officer3.5yrs데이터 없음0.00061%
¥ 19.5m
Stig Ogata
Vice President of Corporate Communications6.6yrs데이터 없음데이터 없음
Tatjana Dragovic
Senior VP and Head of Ethics & Compliance6.7yrs데이터 없음데이터 없음
Nobuaki Tanaka
President of Japan Commercial & Senior Corporate Executive8.4yrs데이터 없음데이터 없음
Jun Kono
Senior Executive Officer & Head of Japan Commercialless than a year데이터 없음데이터 없음
Hideki Shima
Chief Manufacturing Officer & Senior Corporate Executive5.8yrs데이터 없음데이터 없음
Leticia Delgado-Herrera
VP and Rx+ M&D Head5.8yrs데이터 없음데이터 없음

4.8yrs

평균 재임 기간

경험이 풍부한 관리: 4503 의 관리팀은 경험 ( 4.8 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Naoki Okamura
President5.4yrsJP¥461.00m0.0032%
¥ 101.4m
Katsuyoshi Sugita
Chief People Officer1.4yrs데이터 없음0.00061%
¥ 19.5m
Takashi Tanaka
Independent Outside Director3.4yrs데이터 없음데이터 없음
Masahiro Miyazaki
Outside Independent Director1.4yrs데이터 없음0.000060%
¥ 1.9m
Kenji Yasukawa
Chairman of the Board7.4yrsJP¥309.00m0.010%
¥ 318.9m
Tomoko Aramaki
Outside Independent Directorless than a year데이터 없음데이터 없음
Eriko Sakurai
Independent Outside Director2.4yrs데이터 없음데이터 없음
Mika Nakayama
Independent Outside Director2.4yrs데이터 없음데이터 없음
Rie Akiyama
Outside Independent Director1.4yrs데이터 없음데이터 없음
Yoichi Ohno
Outside Independent Director1.4yrs데이터 없음데이터 없음
Rika Hirota
Directorless than a year데이터 없음데이터 없음

1.4yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: 4503 의 이사회는 경험(평균 재직 기간 1.4 년)으로 간주되지 않으므로 새 이사회가 필요합니다.